Please login to the form below

Not currently logged in
Email:
Password:

Oxford Pharmascience adds to board

John Goddard is former head of group strategic planning and business at AstraZeneca
John Goddard Oxford Pharmascience

Oxford Pharmascience has bulked up its board with the appointment of industry veteran John Goddard as independent non-executive director.

Goddard has years of experience in pharma including a spell as head of group strategic planning and business development at AstraZeneca until his retirement in 2010.

He joined AZ after his former company Zeneca merged with Astra in 1999.

Oxford Pharmascience's chair Dave Norwood commented that Goddard's experience in the industry would be valuable as the company initiates the commercialisation of its drug pipeline.

10th March 2014

Share

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Windrose Consulting Group

Founded in 2015, Windrose Consulting Group is a privately-held global strategy firm that partners with life science companies to maximize...

Latest intelligence

JulAug cover image
The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
Chris Ross conducts a literary-inspired review of pharma’s pursuit of communications excellence...
The key to psoriasis innovation? Dispelling the shadow of the JAK inhibitor
Powerful therapies that can improve skin clarity dominate the psoriasis landscape, so why are most patients stuck in a cycle of ineffective topicals? Fishawack Health explores the market and reveals...
Virtual Speaker Program: A Customer Story
Learn how we helped our client develop a virtual speaker program and roll out a series of regional peer-to-peer education sessions....